Pocket Program - CROI

Poster Listings
Session 89 CROI 2013
436 + Cell Count despite Effective ART is Associated
with Elevated Monocyte Activation
and Poor Neurocognitive Performance
Alessandra Bandera* 1 , M Saresella 2 , G Lapadula 1 , A Muscatello 1 ,
I Marventano 2 , S Limonta 1 , V Pastore 1 , E Cappelletti 1 , M Clerici 3 ,
and A Gori 1
1 S Gerardo Hosp, Monza, Italy;; 2 Don C Gnocchi Fndn, Milan, Italy;;
and 3 Univ of Milan, Italy
437
Levels Inversely Correlate
with Processing and Motor Speed in HIV +
Cognitive Complaints with and without HIV-associated
Neurocognitive Disorder
Albert Anderson* 1,2 , J Lennox1,2 , D Loring1 , and W Tyor1 1 2 Emory Univ Sch of Med, Atlanta, GA, US and Grady Hlth System
Infectious Diseases Prgm, Atlanta, GA, US
445 HIV and Aging: New Graph Theoretical Models of rs-fcMRI
Neuropathophysiology
Jewell Thomas*, M Brier, and B Ances
Washington Univ in St. Louis
36 20th Conference on Retroviruses and Opportunistic Infections
c Wednesday, 2:30-4 pm; Hall B2
Session 91–Poster Abstracts
NeuroAIDS Clinical Studies
446 Neurological Characterization of HIV Controllers
Evelyn Lee* 1 , J Peterson 1 , R Walter 1 , J Javerbaum 1 , S Deeks 1 ,
R Price 1 , K Robertson 2 , D Meyerhoff 1 , B Shacklett 3 , and S Spudich 4
1 Univ of California, San Francisco, US;; 2 Univ of North Carolina at
Chapel Hill, US;; 3 Univ of California, Davis, US;; and 4 Yale Univ Sch of
Med, New Haven, CT, US
438
in HIV + Very Late-presenters
Andrea Calcagno* 1 , C Atzori2 , D Imperiale2 , F Lipani1 , S Audagnotto1 ,
G Orofino3 , V Ghisetti3 , G Marietti2 , G Di Perri1 , and S Bonora1 1 2 Univ of Torino, Italy;; Ospedale Maria Vittoria, ASLTO2, Torino, Italy;;
and 3Ospedale Amedeo di Savoia, ASLTO2, Torino, Italy
c Tuesday, 2:30-4 pm; Hall B2
Session 90–Poster Abstracts
(see Session 44 on Wednesday for corresponding Themed Discussion)
Aging and Neurocognitive Function in HIV Infection
439
Cohort Study
Karl Goodkin* 1 , E Miller2 , C Cox3 , S Reynolds3 , D Ostrow4 , O Selnes5 ,
E Martin6 , N Sacktor5 , and J Becker7 1 2 AIDS Hlthcare Fndn, Los Angeles, CA, US;; Univ of California,
Los Angeles, US;; 3Johns Hopkins Univ Bloomberg Sch of Publ Hlth,
Baltimore, MD, US;; 4Univ of Chicago, IL, US;; 5Johns Hopkins Univ Sch
of Med, Baltimore, MD, US;; 6Univ of Illinois at Chicago, US;; and 7Univ of Pittsburgh, PA, US
440 Veterans Aging Cohort Study Index Score Is Associated with
Study
D Franklin Jr1 , R Heaton1 , S Woods1 , S Letendre1 , A Collier2 , D Clifford3 ,
B Gelman4 , J McArthur5 , D Simpson6 , Igor Grant* 1 , and CHARTER Group
1 2 Univ of California, San Diego, US;; Univ of Washington, Seattle, US;;
3 4 Washington Univ, St Louis, MO, US;; Univ of Texas Med Branch,
Galveston, US;; 5Johns Hopkins Univ, Baltimore, MD, US;; and 6Mt Sinai
Sch of Med, New York, NY, US
441
Proteins Characterize Evolving Central Nervous System
Julia Peterson* 1 , H Zetterberg2 , L Hagberg2 , S Spudich3 , M Gisslen2 ,
and R Price1 1 2 Univ of California, San Francisco, US;; Sahlgrenska Academy at Univ of
Gothenburg, Sweden;; and 3Yale Univ, New Haven, CT, US
442
Profiles in Chronic Middle-aged HIV + Individuals
L Cysique1,2 , J Lamoury2 , T Hewitt2,3 , K Taddei4,5,6 , R Martins4,5 , C Chew5 ,
P Price5 , and Bruce Brew* 1,2
1 2 St Vincents Hosp, Sydney, Australia;; Univ of New South Wales, Sydney,
Australia;; 3Notre Dame Univ, Sydney, Australia;; 4Edith Cowan Univ,
Australia;; 5Univ of Western Australia, Perth;; and 6Hollywood Private
Hosp, Nedlands, Australia
443
on Suppressive ART: An Aging Effect of Central Nervous
System Infection?
Jan Jessen Krut* 1 , T Mellberg1 , R Price2 , L Hagberg1 , D Fuchs3 ,
L Rosengren1 , S Nilsson4 , H Zetterberg1,5 , and M Gisslen1 1 2 Sahlgrenska Academy, Univ of Gothenburg, Sweden;; Univ of California,
San Francisco, US;; 3Innsbruck Med Univ, Austria;; 4Chalmers Univ of Tech,
Gothenburg, Sweden;; and 5Univ Coll London, Inst of Neurology, UK
444 Longitudinal Association of HIV-associated Neurocognitive
+
Men
Bryan Smith* 1 , R Skolasky1 , F Mateen1 , J Becker2 , E Martin3 , E Miller4 ,
J Margolick5 , O Selnes1 , N Sacktor1 , and Multictr AIDS Cohort Group
1 2 Johns Hopkins Univ Sch of Med, Baltimore, MD, US;; Univ of Pittsburgh
Sch of Med, PA, US;; 3Univ of Illinois Sch of Med, Chicago, US;; 4David Geffen Sch of Med, Univ of California, Los Angeles, US;; and 5 447 Neurovirological Correlation with HIV-associated
Neurocognitive Disorders and Encephalitis in a HAART-era
Cohort
Benjamin Gelman*
Johns
Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD US
1 , J Lisinicchia1 , S Morgello2 , E Masliah3 ,
D Commins4 , I Grant3 , E Singer5 , S Sherman6 , G Gensler6 , V Soukup1 ,
and Natl NeuroAIDS Tissue Network
1 2 Univ of Texas Med Branch, Galveston, US;; Mt Sinai Med Ctr, New
York, NY, US;; 3Univ of California, San Diego, La Jolla, US;; 4Univ of
Southern California, Los Angeles, US;; 5Univ of California, Los Angeles,
US;; and 6The EMMES Corp, Rockville, MD, US
448
Andrea De Luca* 1,2 , N Ciccarelli1 , P Grima1,3 , M Colafigli1 , M Fabbiani1 ,
E Baldonero1 , A Borghetti1 , E Tamburrini1 , R Cauda1 ,
and S Di Giambenedetto1 1 2 Catholic Univ of the Sacred Heart, Rome, Italy;; Univ of Siena, Italy;;
and 3S Caterina Novella Hosp, Galatina, Italy
449
cART Era: Neuradapt Study
Matteo Vassallo* 1,2 , B Dunais2 , J Durant2 , V Biscay2 , M Laffont3 ,
C Lebrun-Frenay3 , J Cottalorda2 , M Ticchioni2 , C Pradier2 ,
P Dellamonica2 , and Neuradapt Study Group
1 2 Pierre Nouveau Hosp, Cannes, France;; LArchet Hosp, Univ of Nice,
France;; and 3Pasteur Hosp, Univ of Nice, France
450 HIV-associated Neurocognitive Disorders in a Community
Standardized Neuropsychological Assessment
Mark Bloch* 1 , A Carberry1 , J Kamminga2 , M Bailey3 , T Vincent1 ,
D Quan1 , B Brew4,5 , and L Cysique4,5 1 2 Holdsworth House Med Practice, Sydney, Australia;; Macquarie Univ,
Sydney, Australia;; 3Monash Univ, Melbourne, Australia;; 4Univ of New
South Wales, Sydney, Australia;; and 5St Vincents Hosp, Sydney, Australia
451 Trails A Test Improves Performance Characteristics of the
International HIV Dementia Scale to Identify Symptomatic
HIV-associated Neurocognitive Disorder
T Chalermchai1 , J Ananworanich1,2,3 , P Sithinamsuwan4 , S Pinyakorn1 ,
D Clifford5 , R Paul6 , V DeGruttola7 , S Ratto-Kim8 , C Shikuma9 ,
Victor Valcour* 10 , and SEARCH 007 and 011 Study Groups
1South East Asia Res Collaboration with the Univ of Hawaii, Bangkok,
Thailand;; 2Chulalongkorn Univ, Bangkok, Thailand;; 3HIV-NAT Res
Collaboration, Bangkok;; 4Phramongkutklao Hosp, Bangkok, Thailand;;
5 6 Washington Univ in St Louis, MO, US;; Univ of Missouri, St Louis, US;;
7 8 Harvard Sch of Publ Hlth, Boston, MA, US;; Walter Reed Army Inst of
Res, Silver Spring, MD, US;; 9Univ of Hawaii at Manoa, Honolulu, US;;
and 10Univ of California, San Francisco, US
452 High Grade Liver Steatosis and Cognitive Impairment in
HIV + Patients
Pierfrancesco Grima* 1,2 , M Fabbiani1 , A Mondi1 , A D’Avino1 , S
Limiti1 ,
M Colafigli1 , B Milanini1 , E Baldonero1 , R Cauda1 ,
and S Di Giambenedetto1 1 2 Catholic Univ of the Sacred Heart, Rome, Italy and S Caterina Novella
Hosp, Galatina, Italy
453 Minimal Cognitive Impairment in UK HIV + Men Who Have
Sex with Men;; Comparison with the General Population and
across Classification Systems
J McDonnell1 , Fiona Lampe* 1 , L Haddow1 , A Phillips1 , L Sherr1 ,
R Gilson1 , J Harrison2 , A Antinori3 , M Johnson4 , A Rodger1 ,
and CIPHER Study Group
1 2 3 Univ Coll London, UK;; Imperial Coll London, UK;; Natl Inst for
Infectious Diseases, Rome, Italy;; and 4Royal Free Hosp, London, UK
454
455
Progression Rates of Neuro-AIDS and Its Neuropsychological
Patterns in the cART Era
Gabriele Arendt*, E Orhan, and T Nolting
Univ of Dusseldorf, Germany
Performance of Screening Tools for the Detection of
Neurocognitive Impairment in HIV Patients
Andrea Antinori*, P Balestra, P Lorenzini, R Libertone, G Cataldo,
L Giancola, C Pinnetti, and V Tozzi
INMI L Spallanzani, Rome, Italy